Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Resistant HIV1 in Semen
D'Aquila, Richard T.
Vanderbilt University Medical Center, Nashville, TN, United States
Search 92 grants from Richard D'Aquila
Search grants from Vanderbilt University Medical Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
Novel IRES-specific trans acting factors that modulate EV71 translation
Sensory Modification of Cortical Organization
CD2 and T-Cell Adhesion and Activation
Computer and Information Science and Engineering Research Instrumentation
Recently added grants:
Drug Discovery and Structural Biology Core
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
Analytical Pharmacology Core
Multi-omics Mass Spectrometry and Biomarker Discovery Core
Molecular and Cellular Biology of Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI044619-04
Application #
6588766
Study Section
Special Emphasis Panel (ZRG1-AARR-2 (01))
Program Officer
Bell, Dawn L
Project Start
1999-07-01
Project End
2003-06-30
Budget Start
2001-09-01
Budget End
2003-06-30
Support Year
4
Fiscal Year
2001
Total Cost
$243,207
Indirect Cost
Institution
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Related projects
NIH 2001
R01 AI
Drug Resistant HIV1 in Semen
D'Aquila, Richard T. / Massachusetts General Hospital
$69,468
NIH 2001
R01 AI
Drug Resistant HIV1 in Semen
D'Aquila, Richard T. / Vanderbilt University Medical Center
$243,207
NIH 2000
R01 AI
Drug Resistant HIV1 in Semen
D'Aquila, Richard T. / Massachusetts General Hospital
$305,381
NIH 1999
R01 AI
Drug Resistant HIV1 in Semen
D'Aquila, Richard T. / Massachusetts General Hospital
Publications
Zachary, K C; Hanna, G J; D'Aquila, R T
(2001)
Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo.
Clin Infect Dis 33:2075-7
Comments
Be the first to comment on Richard D'Aquila's grant